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Abstract
Acute inflammation is an immediate response to infection and injury characterised by the
influx of granulocytes followed by phagocytosing mononuclear phagocytes. Provided the
antigen is cleared and the immune system of the host is fully functional, the acute inflamma-
tory response will resolve. Until now it is considered that resolution then leads back to
homeostasis, the physiological state tissues experienced before inflammation occurred.
Using a human model of acute inflammation driven by intradermal UV killed Escherichia
coli, we found that bacteria and granulocyte clearance as well as pro-inflammatory cytokine
catabolism occurred by 72h. However, following a lag phase of about 4 days there was an
increase in numbers of memory T cells and CD163+ macrophage at the post-resolution site
up to day 17 as well as increased biosynthesis of cyclooxygenase-derived prostanoids and
DHA-derived D series resolvins. Inhibiting post-resolution prostanoids using naproxen
showed that numbers of tissue memory CD4 cells were under the endogenous control of
PGE2, which exerts its suppressive effects on T cell proliferation via the EP4 receptor. In
addition, we re-challenged the post-resolution site with a second injection of E. coli, which
when compared to saline controls resulted in primarily a macrophage-driven response with
comparatively fewer PMNs; the macrophage-dominated response was reversed by cycloox-
ygenase inhibition. Re-challenge experiments were also carried out in mice where we
obtained similar results as in humans. Therefore, we report that acute inflammatory
responses in both humans and rodents do not revert back to homeostasis, but trigger a hith-
erto unappreciated sequence of immunological events that dictate subsequent immune
response to infection.
Introduction
Following infection the acute inflammatory cascade is initiated with the specific aim of eradi-
cating the pathogen [1]. Thereafter, a sequence of events takes place including catabolism of
pro-inflammatory cytokines and chemokines [2,3], as well as inhibition of granulocyte
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recruitment to the affected site [4]. Of the infiltrated granulocytes the majority have been
shown to die by apoptosis and are cleared by tissue-resident macrophages [5]. This entire pro-
cess is relatively rapid occurring within 3–5 days.
According to current view, upon successful resolution the inflamed tissue returns back to
homeostasis—the cellular and biochemical state present before inflammatory challenge. This
view has been challenged by recent reports which show that resolution is not just the termina-
tion of innate immune response to infection/injury, but leads to cellular and biochemical
events that can influence subsequent adaptive immune responses [6–9]. Indeed, we found that
following resolution of acute peritonitis there was sustained infiltration of myeloid and lym-
phoid cells into the peritoneum that persisted for months [9]. We hypothesised that this post-
resolution infiltrate bridged the gap between innate and adaptive immunity as depleting mye-
loid cells, for instance, during this phase blunted lymph node expansion. Moreover, a popula-
tion of these infiltrated myeloid cells were retained in the peritoneum long-term and dictated
the severity and longevity of subsequent innate immune-mediated responses to secondary
inflammatory stimuli [9,10]. Some infections can also cause “immunological scarring”, such
that despite effective clearance of the inciting stimulus, the site becomes chronically inflamed
rather than reverting to homeostasis [11,12]. Taken together, these reports highlight that our
current understanding of resolution should not be limited to defining it as just the end of
innate immune–mediated responses to infection. Instead, once the clinical signs of inflamma-
tion have abated, the site of inflammation experiences a great deal of immunological activity
occurring at the sub-clinical level that dictates the subsequent long-term physiological fate of
tissues post injury.
Using a recently developed model of self-resolving acute inflammation in healthy
human volunteers we sought to characterise the local immunological events that occur
after resolution of the response. Injecting UV-killed E. coli (UVkEc) into the dermis trig-
gered a robust neutrophilia and localised cytokine flare peaking at 4h. This was followed by
neutrophil clearance alongside monocyte/macrophage infiltration. However, by day three
resolution had occurred at least according to the classical pathological definition of granu-
locyte and antigen clearance as well as reversal of the cardinal signs of heat, redness, swell-
ing and pain. Following resolution, we noted increased numbers of memory T cells,
macrophage populations as well as robust lipid mediator biosynthesis, which we contend




Study approval was obtained from UCL Institutional Ethics Committee (Project ID: 5051/
001). All volunteers provided written informed consent and study procedures were in accor-
dance with the Helsinki Declaration of 1975, revised in 1983.
Study participants
Healthy non-smoking male volunteers (18–50 years) were excluded if they had history of any
chronic inflammatory disease, recent illness (<1 month), vaccination within the last three
months, regularly took prescribed medication, or took any medication in preceding week. Vol-
unteers with history of hypersensitivity to NSAIDs or gastrointestinal ulceration were also
excluded. During the study period, volunteers were asked to refrain from alcohol and heavy
exercise.
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Injection of UV-killed E. coli (UVkEc) and acquisition of inflammatory
exudate
Acute inflammation was triggered by intradermal injection of 1.5 x 107 UV-killed E. coli bacte-
ria suspended in 100 μl of saline in the forearm. Inflammation was allowed to progress for the
duration of the time-point after which a suction blister was raised over the marked injection
site, followed by immediate aspiration of inflammatory exudate. Inflammatory exudate was
centrifuged to separate cells from supernatant. Cells were processed immediately for flow
cytometry and the cell free exudate was frozen into aliquots at -800 C and was analysed later
for soluble mediators. The detailed description of the preparation of UVkEc, intradermal
injection, suction blister technique, exudate collection and processing can be found in refer-
ence [13]. COX-inhibition studies were performed by orally administering 500mg enteric-
coated naproxen tablets, twice daily.
Flow cytometry
Blister cells were suspended in 100 μl of cell staining buffer (PBS with 5% FCS, 0.1% sodium
azide) were incubated for 30 mins on ice with following antibodies: CD3: FITC, CD14: BV605,
CD16: APC, CD19: FITC, CD56: FITC, CD62L: PE-Cy7, CD163: BV421, HLA-DR: BV510,
CD45RO: BV785, CCR7: BV711 (all antibodies were obtained from Biolegend). Stained cell
sample was washed to remove excess antibody and then fixed in 1% paraformaldehyde. Fixed
sample was acquired on BD LSR Fortessa within 4h. Flow cytometry data was analysed by
Flowjo software (Treestar Inc.). Flow cytometric gating strategy employed to identify cell pop-
ulations is as described in reference [13].
Multiplex ELISA
Human pro-inflammatory panel-1 mutiplex ELISA kit (Meso Scale Delivery, USA) was used
to measure cytokines. The cell free blister exudate was diluted in appropriate assay diluent and
the assay was performed as per manufacturer’s instructions.
Immunohistochemistry
A skin punch biopsy (3 mm diameter) was obtained from the site of UVkEc injection at the
specified time point. Baseline biopsy was obtained from forearm of a non-injected volunteer.
Biopsies were immediately transferred to neutral buffered formalin for fixation. Fixed skin
biopsies were embedded in paraffin wax. Four μm thickness sections were collected on the
glass slides and stained for antibodies after unmasking of antigen. Following antibodies were
used: Mouse anti- E. coli LPS antibody (Abcam), Mouse anti-CD163 antibody (Leica). Anti-
body stained slides were developed using 303 diaminobenzedine tetrachloride as the chromo-
gen followed by counterstaining by haematoxylin for localization of nuclei. Appropriate
controls were used throughout. Digital images of the stained slides were obtained on a Nano-
zoomer (Hamamatsu).
Lipid mediator profiling
Blister exudates were placed in 2 volumes ice-cold methanol containing deuterium labelled
PGE2 (d4-PGE2); d4-leukotriene B4, d5- lipoxin A4 and d5-resolvin D2 (500 pg each; Cayman
Chemicals). These were then kept at -20 oC for 45 mins to allow for protein precipitation and
lipid mediators were extracted using C-18 based Solid Phase Extraction as in reference [14].
Methyl formate fractions were brought to dryness using a TurboVap LP (Biotage) and prod-
ucts suspended in water-methanol (80:20 vol:vol) for Liquid Chromatography-tandem mass
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spectrometry (LC- MS/MS) based profiling. Here a Shimadzu LC-20AD HPLC and a Shi-
madzu SIL- 20AC autoinjector (Shimadzu, Kyoto, Japan), paired with a QTrap 5500 (ABSciex,
Warrington, UK) were utilised and operated as described in reference [14]. To monitor each
lipid mediator and deuterium labelled internal standard, a Multiple Reaction Monitoring
(MRM) method was developed using parent ions and characteristic diagnostic ion fragments
as in reference [14]. This was coupled to an Information Dependent Acquisition and an
Enhanced Product Ion scan. Identification criteria included matching retention time (RT) to
synthetic standards and at least six diagnostic ions in the MS-MS spectrum for each molecule.
Calibration curves were obtained for each molecule using authentic compound mixtures and
deuterium labelled lipid mediator at 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, 100, and 200 pg. Linear
calibration curves were obtained for each lipid mediator, which gave r2 values of 0.98–0.99.
Mononuclear/T cell interactions studies
Forty millilitres of blood was taken from healthy volunteers in heparin vacutainers and diluted
1:3 in hanks balanced salt solution (HBSS, Life technologies), and layered on Ficoll (GE
Healthcare), spun at low acceleration. The peripheral blood mononuclear cells (PBMC) layer
was carefully removed and washed in PBS. PBMC’s were incubated with anti-human CD3
beads (Miltenyi Biotec) and the flow through was plated and incubated with 1 μg/ml VZV
(Virusys lot A1446100) for 4 h with or without PGE2 (Cayman Chemical, see legends for con-
centrations) or 25% blister fluid from day 17 of E. coli blister model. Cells were washed and
incubated with CD3 cells with or without PGE2 at a ratio of 1:3 PBMC to CD3 cells respec-
tively for 3 days. Proliferation was measured with anti-Ki67.
Animal studies and drug dosing
Male C57Bl6/J mice (aged 8–10 weeks) were maintained in accordance with United Kingdom
Home Office regulations (Project Licence number P69E3D849, Establishment Licence number
X7069SDD). Male C57Bl6/J mice (15 in total) were maintained in an enriched environment
and allowed water and food ad libitum. Peritonitis was induced by injecting sonicated 0.1 mg/
mouse zymosan A (Sigma) intraperitoneally. While this type of inflammatory response is
localised in nature and does not cause pain or distress, animals were nonetheless monitored
daily. For re-challenge experiments 40000 CFU Streptococcus pneumoniaeova323-339/mouse
were injected into the peritoneal cavity 14 days after zymosan injection. This secondary stimu-
lus was allowed to progress for 4 h during which animals were constantly monitored with no
clinical manifestation of pain or systemic inflammation observed during this time. Streptococ-
cus pneumoniaeova323-339 was obtained from Prof Jeremy Brown, UCL. Animals were sacrificed
by excess carbon dix oxide inhalation. For cyclooxygenase inhibition studies, naproxen was
dosed at 30mg/kg/day starting from day 7 after zymosan injection.
Results
UV-killed E. coli triggers acute resolving inflammation in healthy humans
The intradermal injection of 1.5x107 UVkEc into the forearm of healthy male volunteers
caused an increase in microvascular hyperaemia around the site of injection that persisted
from 4 h to 24 h and had resolved by day 3, Fig 1A. Long before the resolution of the microvas-
cular responses was the clearance of the UVkEc, which was detectable at the injection site at
the peak of the acute immune response (4 h), but was largely cleared by 24 h being undetect-
able at 48 h, Fig 1B. Finally, using negative pressure suction blisters to acquire cells and inflam-
matory mediators from the inflamed site we found that PMN numbers (Fig 1C) as well as
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Fig 1. Acute inflammatory response to intradermal UVkEc injection. Acute inflammation was triggered in the ventral aspect of
forearm of healthy volunteers by the intradermal injection of 1.5 x 107 UV-killed E. coli (UVKEc) suspended in 100 μl of sterile saline.
Vascular hyperaemia at the site was assessed by laser Doppler imager and the representative flux images after a specified time point
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typical pro-inflammatory cytokine levels (IL-6, TNFα and IL-1β) peaked at 4 h, but were unde-
tectable by 24 h, Fig 1D–1F. Thus, the injection of UVkEc bacteria into the forearm of healthy
volunteers generated a transient acute inflammatory response that resolved by 72 h.
Post-resolution infiltration of lymphocytes and CD163+ macrophages
Despite the resolution of acute inflammation, at least in line with the classical definition of
antigen, granulocyte and cytokine clearance, we observed an increase in numbers of CD4+/
CD45RO+/CCR7- (Fig 2A) and CD8+/CD45RO+/CCR7- memory T cells (Fig 2B) accumulat-
ing in the post-resolved tissue from D7; a trend towards a post-resolution increase in CD56+
NK cells was also detected, Fig 2C. This increase in T cells was associated with an equivalent
increase in the T cell mitogens IL-15 as well as IL-7, Fig 2D and 2E.
In addition, polychromatic flow cytometry analysis of blister cells showed an initial peak in
numbers of CD14+/HLA-DR+ monocytes/macrophages at 8 h and then again at 24 h post
UVkEc injection, Fig 3A. However, closer analysis of these data up to day 14 suggested a
potential increase in macrophages long after inflammation resolved. Indeed, this accumulation
was more apparent when 3mm punch biopsies were carried out at day 14, which revealed a
discrete population of perivascular CD163+ macrophages that were greater in number when
compared to naïve skin tissue, Fig 3B. Measuring soluble mediators that control macrophage
trafficking and function in the elicited blister fluid demonstrated a biphasic profile in MCP-1
(Fig 3C) mirroring that of macrophage kinetics during the first three days of the response, Fig
3A. We also found increases in IP-10, MDC and MCP-4 (Fig 3D–3F) during the acute phase
of the response with levels MCP-4 remaining around 100pg/ml up to day 14.
Post-resolution lipid mediator biosynthesis
Using LC/MS-MS based profiling we identified from all three major bioactive metabolomes in
elicited blister exudates including D-series resolvins and prostaglandins. These were identified
in accordance with published criteria that include retention time and MS-MS spectra [14] (S1
Fig). Quantitation of identified mediators in blister fluids revealed an expected increase in lev-
els of PGE2 as well as TxB2 during the early onset phase (8h), which reduced back to baseline
levels by 24 h post UVkEc injection, Fig 4A and 4B. However, from day 14-post UVkEc injec-
tion or 11 days post classical resolution we noted a second rise in these prostanoids as well as
PGD2 and PGF2α, Fig 4C and 4D. Concentrations of pro-resolving mediators including resol-
vin D5 (RvD5), lipoxin B4 (LXB4), and the LX pathway marker 5,15 diHETE also increased at
day 14. Whereas RvE3 concentrations were only elevated during the initial phases of the
inflammatory response, demonstrating a differential regulation of lipid mediator biosynthesis
at the site Fig 4E–4H.
Post-resolution PGE2 maintains T cell numbers and proliferation
To determine the pathophysiological relevance of these findings we dosed volunteers with the
non-selective NSAID, naproxen, starting from day 9 post UVkEc injection and examined the
are shown here (A). A 3 mm skin punch biopsy was taken from the inflamed site under local anaesthesia at the specified interval and
formalin fixed paraffin embedded (FFPE) skin sections were probed by immunohistochemistry for E. coli LPS. The representative
sections are shown here (B). A suction blister was raised over the inflamed site at the specified interval to collect the inflammatory
exudate. Exudate was centrifuged to separate cells from the supernatant. The immune cell subsets were identified by polychromatic
flow cytometry. The total count/ml of neutrophils in the inflammatory exudate at specified interval is shown here (C). IL-6, TNFα and
IL1β in the cell free exudate were measured using multiplex ELISA and their concentrations in the exudate at the specified intervals are
shown here (D-F, respectively). n = 3 for each time point. Data presented as mean ± SEM.
https://doi.org/10.1371/journal.pone.0186964.g001
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Fig 2. Post-resolution tissue accumulation of memory T cells and lymphocyte mitogens. Acute inflammation was triggered in the
ventral aspect of forearm of healthy volunteers by the intradermal injection of 1.5 x 107 UV-killed E. coli (UVKEc) suspended in 100 μl of
sterile saline. A suction blister was raised over the inflamed site at the specified interval to collect the inflammatory exudate. Exudate
was centrifuged to separate cells from the supernatant. The immune cell subsets were identified by polychromatic flow cytometry. The
numbers of CD4+/CD45RO+/CCR7- (A), CD8+/CD45RO+/CCR7- memory T cells (B) and CD56+ NK cells (C) at the specified interval
are shown here. IL-15 (D) and IL-7 (E) in the cell free exudate were measured using multiplex ELISA and their concentrations in the
exudate at the specified intervals are shown here. n = 3 for each time point. Data presented as mean ± SEM.
https://doi.org/10.1371/journal.pone.0186964.g002
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site at day 14; our specific aim was to determine what role PGs play during post-resolution
biology. We found that naproxen caused an increase in numbers of CD4+/CD45RO+/CCR7-
but not CD8+/CD45RO+/CCR7- memory T cells, Fig 5A and 5B, respectively. Taking this fur-
ther we isolated peripheral blood CD3+ T cells from chicken pox-exposed volunteers to deter-
mine the effects of PGE2 on memory T cell proliferation. Using concentrations of PGE2 found
in post-resolution tissues, we found that this prostaglandin inhibited proliferation of VZV
antigen-specific CD3+ T cells (Fig 5C) in an EP4 but not EP2 dependent manner, Fig 5D;
CD3+ T cells from chicken pox naïve donors acted as a negative control, Fig 5E.
Post-resolution PGE2 determines responses to secondary stimuli
Groups of volunteers were injected with either saline into one arm or UVkEc into the other.
14 days later UVkEc was injected into both sites—the original saline and UVkEc injected sites.
Blister was raised at the site 4 hr after the secondary UVkEc challenge. The purpose of this
experiment was to determine how tissues respond to secondary inflammatory stimuli follow-
ing inflammatory resolution. Its transpires that tissue that experienced acute resolving inflam-
mation elaborated substantially more CD14+ macrophages (Fig 6A) and comparatively fewer
PMNs, Fig 6B. Repeating these experiments, but dosing volunteers with naproxen to inhibit
the second post-resolution rise in prostanoids, revealed that this macrophage-dominated
response was driven, in part, by cyclooxygenase-derive lipid mediators as numbers of CD14+
cells in inflammation experienced tissues were substantially reduced, Fig 6A; there was little
effect on PMN numbers in these experiments.
These data challenge the idea that resolution leads tissue back to homeostasis, the physio-
logical state they experienced before inflammation, but that events specific to the resolution
response elicit a sequence of immunological events that control future responses to foreign
and endogenous antigens and that are key in maintaining immune tolerance. Indeed, the com-
position of the post-resolution tissue in mice is immunologically similar to that seen in post-
resolution human skin. Using zymosan model, we injected mice at day 14 (the time point of
maximal lymphoid and myeloid infiltration as well as prostanoid synthesis) with S. pneumonia
and determined the composition of the cavity 4h later. As with humans, post-inflamed murine
tissues mounted a predominantly macrophage-driven response that was reversed with
naproxen, Fig 6C. Unlike humans, however, numbers of PMNs were paradoxically elevated
following cyclooxygenase inhibition in rodents, Fig 6D.
Therefore, acute inflammatory responses in both humans and rodents do not revert back to
homeostasis but trigger a hitherto unappreciated sequence of immunological events that dic-
tate subsequent immune response to infection.
Discussion
In this report, we show that an i.d. injection of UV-killed E. coli in forearms of healthy male
volunteers triggered a classical acute inflammatory flare as characterised by increased
Fig 3. Post-resolution tissue accumulation of macrophages. Acute inflammation was triggered in the ventral aspect of forearm
of healthy volunteers by the intradermal injection of 1.5 x 107 UV-killed E. coli (UVKEc) suspended in 100 μl of sterile saline. A
suction blister was raised over the inflamed site at the specified interval to collect the inflammatory exudate. Exudate was
centrifuged to separate cells from the supernatant. The immune cell subsets were identified by polychromatic flow cytometry. The
numbers of CD14+ mononuclear cells at the specified interval are shown here (A). A 3mm skin punch biopsy was taken from the
inflamed site under local anaesthesia at the specified interval and the formalin fixed paraffin embedded (FFPE) skin sections were
probed by immunohistochemistry for CD163. The representative sections are shown here (B). MCP-1, IP-10, MDC and MCP-4
(panels C-F) in the cell free exudate were measured using multiplex ELISA and their concentrations in the exudate at the specified
intervals are shown here (C). n = 3 for each time point. Data presented as mean ± SEM.
https://doi.org/10.1371/journal.pone.0186964.g003
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Fig 4. Increased lipid mediator biosynthesis during post-resolution biology. Acute inflammation was triggered in
the ventral aspect of forearm of healthy volunteers by the intradermal injection of 1.5 x 107 UV-killed E. coli (UVKEc)
suspended in 100 μl of sterile saline. A suction blister was raised over the inflamed site at the specified interval to collect
Resolution of acute inflammation leads to adapted homeostasis
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the inflammatory exudate. Lipid mediators in the cell free exudate were analysed by liquid chromatography tandem
mass spectrophotometry (LC MS/MS). The levels of PGE2 (A), TXB2 (B), PGD2 (C), PGF2α (D), LXB4 (E), 5,15-diHETE
(F), RvD5 (G), 5,15 diHETE (G) and RvE3 (H) at specified interval are shown here. n = 3 for each time point. Data
presented as mean ± SEM.
https://doi.org/10.1371/journal.pone.0186964.g004
Fig 5. Inhibition of post-resolution prostanoids increases numbers of local memory CD4+ T cells. Acute inflammation was triggered in
the ventral aspect of forearm of healthy volunteers by the intradermal injection of 1.5 x 107 UV-killed E. coli (UVKEc) suspended in 100 μl of
sterile saline. Inflammation was allowed to progress for 9 days after which volunteers were administered naproxen (500 mg, BD) orally for six
days to block the rise in post-resolution prostanoids. On day 14 suction blister were elicited to enumerate cell profiles focusing on CD4+/
CD45RO+/CCR7- (A) and CD8+/CD45RO+/CCR7- memory T cells (B). To determine what effect prostanoids have on memory T cell function,
peripheral blood CD3+ cells were isolated from chicken pox-exposed individuals and incubated with varicella zoster antigen with/without PGE2
at concentrations found in post-resolution tissue (C) with/without EP 2/4 antagonists (D) while CD3+ cells from chicken pox naïve individuals
were used as negative controls (E). n = 3 for each time point. Data presented as mean ± se. *p0.05, **p0.01; as determined by ANOVA
followed by Bonferroni t test or by two-tailed Student’s t test.
https://doi.org/10.1371/journal.pone.0186964.g005
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microvascular hyperaemia around the injection site. In addition, there was PMN infiltration,
which peaked alongside cytokine/chemokine synthesis at 4 h with both of these acute
Fig 6. Post-resolution tissues mount a predominantly macrophage driven response that is cyclooxygenase mediated.
Volunteers were injected intradermally with 1.5 x 107 UV-killed E. coli (UVKEc) suspended in 100 μl of sterile saline in one forearm and
100μl of sterile saline only in the contralateral forearm. Inflammation was allowed to progress for 9 days after which one group of
volunteers were administered naproxen (500 mg, BD) orally for six days to block the rise in post-resolution prostanoids and the other
group remained untreated. On day 14, the forearm sites on all volunteers were re-injected with UVKEc and a suction blister was raised
over the inflamed site at 4hr to collect inflammatory exudate. The number of mononuclear cells (A) and neutrophils (B) in the saline
injected arm, untreated group (naive); UVKEc injected arm, untreated group (post-resolution); saline injected arm, naproxen treated
group (naive + naproxen) and UVKEc injected arm, naproxen treated group (post-resolution + naproxen) are shown here. For mouse
experiments (panels C and D), 0.1 mg zymosan was injected in the peritoneum of male c57bl/6 mice. 14 days later either saline or live
S. pneumoniae were injected i.p. and 4 h later the composition of the peritoneum was determined by polychromatic flow cytometry;
naproxen was dosed from day 7. For human studies there were n = 3 volunteers for each group, while there were n = 5 mice for rodents
studies/group. Data presented as mean ± se. *p0.05, **p0.01; as determined by ANOVA followed by Bonferroni t test or by two-
tailed Student’s t test.
https://doi.org/10.1371/journal.pone.0186964.g006
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inflammatory parameters along with vascular flow subsiding within 24–72 h. However, there
was lag phase of a few days after which time we noted increased numbers of memory T cells as
well as CD163+ macrophages within the post-resolved injection site as well as robust prosta-
noid and pro-resolving mediator (RvD5 and LXB4) biosynthesis. Its transpires that prosta-
noids control the numbers of memory CD4+ T during this post-resolution phase as dosing
volunteers with a COX inhibitor, naproxen, caused an increase in memory CD4+ T cells num-
bers within the skin; findings that were verified in vitro to be through the EP2 receptor. Indeed,
re-introducing a second stimulus back into the post-resolved tissue result in an increase in
macrophage numbers compared to responses expected from naïve tissues injected with the
same inoculum. In contrast, there were comparatively fewer PMNs; these effects were partially
prostanoid mediated. Collectively, these data show that in healthy male human volunteers res-
olution of acute inflammation does not revert back to homeostasis, but triggers a prolonged
phase of discreet immunological activity that affects responses to subsequent infection. We
describe these processes as “resolution leading to adapted homeostasis” and most likely has a
role in maintaining immune tolerance.
There is also evidence of immune dysfunction leading to chronic disease occurring long
after clearance of the infectious stimulus. For instance, in a murine model of Sendai-induced
para-influenza, despite clearing the infection mice progressed to develop an asthma-like dis-
ease mediated by sustained activity of natural killer T cells driving macrophages to produce
interleukin-13 [11]. More recently, mice that received a single inoculum of Yersinia pseudotu-
berculosis experienced immune disruption in the gut weeks after bacterial clearance [12]. This
disruption was characterised by lymphatic leakage in the mesenteric adipose tissue that redi-
rected dendritic cells to the adipose compartment thereby preventing their proper accumula-
tion in the mesenteric lymph node. Consequently, mucosal immune functions, including
tolerance and protective immunity, were persistently compromised. Thus, even if the inciting
stimulus is cleared, there is evidence of local “immunological mal-adaption”, predisposing tis-
sues to chronic inflammation occurring months or years after the initial exposure; at least in
response to some infections. However, the nature of this post-inflammation, immune mal-
adaptation is not clearly understood and further research is warranted in this area.
As a result of the established effects of NSAIDs on the inflammatory response, PGE2 has
always been considered as pro-inflammatory. However, its role in the wider innate and adap-
tive immune response is far more complex. For instance, while PGE2 can promote the activa-
tion, maturation and migration of dendritic cells, it’s been widely demonstrated to suppress
both innate and antigen-specific immunity at multiple molecular and cellular levels [15,16].
Indeed, its complex role in adapted immunity was further resolved when it was found that it
can suppress the differentiation of functionally-competent Th1-inducing DCs[17]. In fact, it
was recently reported that the resulting “PGE2-DC” was a myeloid-derived suppressor cells
capable of suppressing CTL responses [18–21]. PGE2 also directly inhibits IL-2 and the respon-
siveness of T cells to IL-2 thereby suppressing the activation and expansion of antigen-specific
T cells [22,23]. PGE2 and other cAMP-elevating agents also act on humoral immunity as it
enhances immunoglobulin class switching [15] as well as V(D)J recombination activity in pre-
B-cell lines [24]. Thus, PGE2 exerts multiple modulatory effects on innate and adaptive immu-
nity with its predominant effect/s most likely being context dependent. PGE2 is also linked
with promoting the formation of pro-resolving mediators, where in a cAMP dependent man-
ner it upregulates the expression of 15-lipoxygenase type 1 in human leukocytes which is the
initiating enzyme in the biosynthesis of resolvins, protectins and lipoxins [25,26].
In contrast, the role of thromboxane in immune responses is less well described. Nonethe-
less, as a result of its vasoconstrictive properties thromboxane negatively regulates the spread
of bacterial infections as well as T cell proliferative responses [27–29]. More recently,
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thromboxane has been shown to play a role in regulating the manner by which draining
lymph nodes respond to vaccines and foreign antigens, playing a key role in the phenomenon
of “lymph node shut down”. This is where, in steady state, the rate of lymph flow and output of
cells in the efferent lymph is constant, but within hours of antigen or adjuvant injection there
is a transitory decrease of lymphocytes exiting the efferent lymph [30–32]. Lymph node shut-
down is an event thought to facilitate the development of adaptive immunity. Lipid mediators,
including thromboxane, are thought to be the critical component in this process [31,33]. Thus,
it must be appreciated that the role of prostanoids in immunity stretches far beyond that of
acute inflammation where they are implicated in driving heat, redness, swelling and pain.
Indeed, with the recognition of this post-resolution phase of inflammation a new role in regu-
lating immune tolerance will become more apparent in time.
While we have only taken these studies to day 17 post E. coli injection, we suspect from pre-
vious work [9] that this post-resolution phase leading to “adapted homeostasis” progresses for
a number of weeks if not months. It is also surprising that the increased local immunological
activity is clinically silent, specifically that despite elevation in factors like prostanoids, which
are known to contribute to pain, oedema and redness, these cardinal signs of inflammation are
not apparent on the skin surface. It is also remarkable that this immunologically modified tis-
sue should react so differently to secondary stimuli in terms of the cellular response mounted,
which was predominantly macrophage mediated.
In summary, we report a novel sequence of events specific to resolution of acute inflamma-
tion in healthy humans, leading to “adapted homeostasis” that we propose might be essential
for the maintenance of immune tolerance to endogenous antigens. We suspect that post-reso-
lution prostanoid biosynthesis act as an internal checkpoint central to preventing the develop-
ment of diseases driven by autoimmunity.
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